Internet Stroke Center Home Stroke Education for Clinicians & Students
 

Patients & Families   Health Professionals   Clinical Trials   About   Home 

 Stroke Education
Section Home
Glossary of
Neurological Terms

 Stroke Management
Thrombolytic Case Management Series
CT Learning Tool
Evaluation & Diagnosis
Stroke Care for EMT's & Paramedics
Management of Oral Anticoagulant Therapy
 Brain Anatomy
Anatomy of the Brain
Blood Vessels of the Brain
Pathogenesis & Pathophysiology
 Brain Imaging
Neurology Image Library
CT & MRI Criteria for Infarction & Hemorrhage
Guide to Imaging Techniques
MRI Compared to CT
 Stroke Facts
Epidemiology of Stroke
Stroke Risk Factors
Types of Stroke

 Search

Search the ISC 
Search the Web


Stroke Prevention in Atrial Fibrillation: Part II

Notes:
The intensity of anticoagulation at the time of stroke in AF patients assigned to warfarin is illustrated. The majority of strokes that were documented in the “warfarin groups” of the original five trials occurred in patients who were not taking anticoagulant therapy at the time of the event 21-26. The shaded area illustrates the ACCP recommended range of INR 2.0–3.019.

Back

Contents

Next

Acknowledgments:
The content of this presentation was prepared by Dr. Gregory Albers of the Stanford Stroke Center.

 

This site is a non-profit, educational service of Washington University School of MedicineInternet Stroke Center at Washington University:
TOP | HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997 - 2007 Internet Stroke Center. All rights reserved.

The information in this web site is not a substitute for medical advice or treatment.
Consultation with your doctor or health care professional is recommended.